Flaxseed oil supplementation manipulates correlations between serum individual mol % free fatty acid levels and insulin resistance in type 2 diabetics. Insulin resistance and percent remaining pancreatic β-cell function are unaffected
Objectives. Elevated total serum free fatty acids (FFAs) concentrations have been suggested, controversially, to enhance insulin resistance and decrease percent remaining β-cell function. However, concentrations of individual serum FFAs have never been published in terms of their relationship (correlation) to homeostatic model assessment-insulin resistance (HOMA-IR) and percent remaining β-cell function (HOMA-%β) in the type 2 diabetics (T2Ds). Alpha-linolenic acid consumption has a negative correlation with the insulin resistance, which in turn is negatively correlated with the remaining β-cell function. The primary objective was to test the hypothesis that there would be different relationship (correlation) between the blood serum individual free FFA mol % levels and HOMA-IR and/or HOMA-%β in T2D. The secondary objective was to test the hypothesis that flaxseed oil, previously being shown to be ineffective in the glycemic control in T2Ds, may alter these correlations in a statistically significant manner as well as HOMA-IR and/or HOMA-%β.
Methods. Patients were recruited via a newspaper advertisement and two physicians have been employed. All the patients came to visit one and three months later for a second visit. At the second visit, the subjects were randomly assigned (double blind) to flaxseed or safflower oil treatment for three months, until the third visit.
Results. Different statistically significant correlations or trends towards among some serum individual free FFA mol % levels and HOMA-IR and HOMA-%β, pre- and post-flaxseed and safflower oil supplementation were found. However, flaxseed oil had no impact on HOMA-IR or HOMA-%β despite statistically significant alterations in correlations compared to baseline HOMA-IR.
Conclusions. The obtained data indicate that high doses of flaxseed oil have no statistically significant effect on HOMA-IR or HOMA-%β in T2Ds, probably due to the additive effects of negative and positive correlations.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Armoni M Harel C Bar-Yoseph F Milo S Karnieli E. Free fatty acids repress the GLUT4 gene expression in cardiac muscle via novel response elements. J Biol Chem 280 34786–34795. 2005.
Asp ML Collene AL Norris LE Cole RM Stout MB Tang SY Hsu JC Belury MA. Time-dependent effects of safflower oil to improve glycemia inflammation and blood lipids in obese post-menopausal women with type 2 diabetes a randomized double-masked crossover study. Clin Nutr 30 443–449 2011.
Barre DE Griscti O Mizier-Barre KA Hafez K. Flaxseed oil and lipoprotein (a) significantly increase bleeding time in type 2 diabetes patients in Cape Breton Nova Scotia Canada. J Oleo Sci 54 347–354 2005a.
Barre DE Griscti O Mizier-Barre KA Hafez K. The mechanism by which flaxseed oil consumption increases bleeding time in patients with type 2 diabetes in Cape Breton Nova Scotia Canada is independent of lipoprotein (a) concentration. J Oleo Sci 54 617–625 2005b.
Barre DE Mizier-Barre KA Griscti O Hafez K. High dose flaxseed oil supplementation may affect fasting blood serum glucose management in human type 2 diabetics. J Oleo Sci 57 269–273 2008.
Blaak EE. Fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutr Soc 62 753–760 2003.
Boden G. Obesity insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 18 139–143 2011.
Butler TJ Barriocanal LA Walker M. Elevated plasma non-esterified fatty acid levels and insulin secretion in non-diabetic relatives of type 2 diabetic patients. Clin Endocrinol (Oxf) 55 349–355 2001.
Crochemore IC Souza AF de Souza AC Rosado EL. ω-3 polyunsaturated fatty acid supplementation does not influence body composition insulin resistance and lipemia in women with type 2 diabetes and obesity. Nutr Clin Pract 27 553–560 2012.
De Caterina R Madonna R Bertolotto A Schmidt EB. n-3 fatty acids in the treatment of diabetic patients biological rationale and clinical data. Diabetes Care 30 1012–1026 2007.
Delarue J Magnan C. Free fatty acids and insulin resistance Curr Opin Clin Nutr Metab Care 10 142–148 2007.
Eriksson J Saloranta C Widen E Ekstrand A Franssila-Kallunki A Schalin C Groop L. Non-esterified fatty acids do not contribute to insulin resistance in persons at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34 192–197 1991.
Eyjolfson V Spriet LL Dyck DJ. Conjugated linoleic acid improves insulin sensitivity in young sedentary humans. Med Sci Sports Exerc 36 814–820 2004.
Ezaki O Takahashi M Shigematsu T Shimamura K Kimura J Ezaki H Gotoh T. Long-term effects of dietary alpha-linolenic acid from perilla oil on serum fatty acids composition and on the risk factors of coronary heart disease in Japanese elderly subjects. J Nutr Sci Vitaminol (Tokyo) 45 759–772 1996.
Fontes G Semache M Hagman DK Tremblay C Shah R Rhodes CJ Rutter J Poitout V. Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells. Diabetes 58 2048–2058 2009.
Foster M Petocz P Caterson ID Samman S. Effects of zinc and α-linolenic acid supplementation on glycemia and lipidemia in women with type 2 diabetes mellitus a randomized double-blind placebo-controlled trial. Journal of Diabetes Research and Clinical Metabolism 2 3 2013.
Glauber H Wallace P Griver K Brechtel G. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 108 663–668 1998.
Goh Y Jumpsen J Ryan E Clandinin M. Effect of omega 3 fatty acid on plasma lipids cholesterol and fatty acid content in NIDDM patients. Diabetologia 40 45–52 1997.
Grapov D Adams SH Pedersen TL Garvey WT Newman JW. Type 2 diabetes associated changes in the plasma non-esterified fatty acids oxylipins and endocannabinoids. PLoS One 7 e48852 2012.
Hamazaki K Itomura M Hamazaki T Sawazaki S. Effects of cooking plant oils on recurrent aphthous stomatitis a randomized placebo-controlled double-blind trial. Nutrition 22 534–538 2006.
Karpe F Dickmann JR Frayn KN. Fatty acids obesity and insulin resistance time for a reevaluation. Diabetes 10 2441–2449 2011.
Kelpe CL Moore PC Parazzoli SD Wicksteed B Rhodes CJ Poitout V. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem 278 30015–30021 2003.
Liu L Li Y Guan C Li K Wang C Feng R Sun C. Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC-MS and multivariate statistical analysis. J Chromatogr B Analyt Technol Biomed Life Sci 878 2817–2825 2010.
Hawkins M Tonelli J Kishore P Stein D Ragucci E Gitig A Reddy K. Contribution of Elevated Free Fatty Acid Levels to the Lack of Glucose Effectiveness in Type 2 Diabetes. Diabetes 52 2748–2758 2003.
Maris M Waelkens E Cnop M D’Hertog W Cunha DA Korf H Koike T Overbergh L Mathieu C. Oleate-induced beta cell dysfunction and apoptosis a proteomic approach to glucolipotoxicity by an unsaturated fatty acid. J Proteome Res 10 3372–3385 2011.
Matthews DR Hosker JP Rudenski AS Naylor BA Treacher DF Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 412–419 1985.
McManus R Clandinin M Jumpson J Finegood DT Clandinin MT Ryan EA. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type 2 diabetes. Diabetes Care 19 463–467 1996.
Mehta A Oeser AM Carlson MG. Rapid quantitation of free fatty acids in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 719 9–23 1998.
Montori V Wollan P Farmer A Dinneen S. Fish oil supplementation in type 2 diabetes. Diabetes Care 23 1407–1415 2000.
Moore PC Ugas MA Hagman DK Parazzoli SD Poitout V. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes 53 2610–2616 2004.
Morita S Shimajiri Y Sakagashira S Furuta M Sanke T. Effect of exposure to non-esterified fatty acid on progressive deterioration of insulin secretion in patients with Type 2 diabetes a long-term follow-up study. Diabet Med 29 980–985 2012.
Muramatsu T Yatsuya H Toyoshima H Sasaki S Li Y Otsuka R Wada K Hotta Y Mitsuhashi H Matsushita K Murohara T Tamakoshi K. Higher dietary intake of alpha-linolenic acid is associated with lower insulin resistance in middle-aged Japanese. Prev Med 50 272–276. 2010.
Nakamura N Hamazaki T Kobayashi M Ohta M Okuda K. Effects of eicosapentaenoic acids on remnant like particles cholesterol concentrations and plasma fatty acid composition in patients with diabetes mellitus. In vivo 12 311–314 1998.
Nettleton J Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes. J Am Dietetic Assoc 105 428–440 2005.
Newens KJ Thompson AK Jackson KG Wright J Williams CM. Acute effects of elevated NEFA on vascular function a comparison of SFA and MUFA. Br J Nutr 105 1343–1351 2011.
Wang DQ Liu XL Rong QF Han L Zhao NQ. Alpha-linolenic acid improves insulin sensitivity in obese patients. Zhonghua Yi Xue Za Zhi 93 132–134 2013.
Oprescu AI Bikopoulos G Naassan A Allister EM Tang C Park E Uchino H Lewis GF Fantus IG Rozakis-Adcock M Wheeler MB Giacca A. Free fatty acid-induced reduction in glucose-stimulated insulin secretion evidence for a role of oxidative stress in vitro and in vivo. Diabetes 56 2927–2937 2007.
Parker SM Moore PC Johnson LM Poitout V. Palmitate potentiation of glucose-induced insulin release a study using 2-bromopalmitate. Metabolism 52 1367–1371 2003.
Plourde M Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 32 619–634 2007.
Poitout V Hagman D Stein R Artner I Robertson RP Harmon JS. Regulation of the insulin gene by glucose and fatty acids. J Nutr 136 873–876 2006.
Poitout V Robertson RP. Glucolipotoxicity fuel excess and beta-cell dysfunction. Endocr Rev 29 351–366 2008.
Poitout V Amyot J Semache M Zarrouki B Hagman D Fontes G. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 1801 289–229 2010.
Reaven GM Chen Y. Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus. Am J Med 85 106–112 1988.
Rivellese AA Maffettone A Iovine C Di Marino L Annuzzi G Mancini M Riccardi G. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care 19 1207–1213 1996.
Robertson RP Harmon J Tran PO Poitout V. Beta-cell glucose toxicity lipotoxicity and chronic oxidative stress in type 2 diabetes. Diabetes 53 119–124 2004.
Roscoe JT. Fundamental Research Statistics for the Behavioral Sciences. Second Edition. Holt Reinhart and Winston Montreal 217 1975.
Salgin B Ong KK Thankamony A Emmett P Wareham NJ Dunger DB. Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes. J Clin Endocrinol Metab 97 302–309 2012.
Stefan N Kantartzis K Celebi N Staiger H Machann J Schick F Cegan A Elcnerova M Schleicher E Fritsche A Haring HU. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care 33 405–407 2010.
Taylor CG Noto AD Stringer DM Froese S Malcolmson L. Dietary milled flaxseed and flaxseed oil improve N-3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J Am Coll Nutr 29 72–80 2010.
Wallace TM Levy JC Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 27 1487–1495 2004.
Woodman R Mori T Burke V Puddey IB Watts GF Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control blood pressure and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 76 1007–1015 2002.
Yang J Xu G Hong Q Liebich HM Lutz K Schmulling RM Wahl HG. Discrimination of Type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. J Chromatogr B Analyt Technol Biomed Life Sci 813 53–58 2004.
Ye J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr Metab Immune Disord Drug Targets 7 65–74 2007.
Yi L He J Liang Y Yuan D Gao H Zhou H. Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients. Chem Phys Lipids 150 204–216 2007.